HIFU: A Revolutionary Non-Invasive Therapy Transforming Cancer and Uterine Health in Nigeria
High-Intensity Focused Ultrasound (HIFU) is rapidly emerging as a groundbreaking treatment modality, revolutionizing the management of prostate cancer, benign prostatic hyperplasia (enlargement), uterine fibroids, and other related conditions. Specialist hospitals across Nigeria are increasingly adopting this advanced, non-invasive therapy, offering patients a path to effective treatment with significantly reduced complications, shorter hospital stays, and faster recovery times. The integration of HIFU into Nigeria’s medical landscape signifies a notable leap forward in the nation’s embrace of cutting-edge medical technologies.
HIFU, a minimally invasive procedure, employs focused ultrasound waves to precisely target and eradicate diseased tissue without the need for surgical incisions. This precision targeting is crucial in preserving surrounding healthy organs and functions, a significant advantage over traditional treatment methods.
The Genesis and Evolution of HIFU
The concept of using focused ultrasound for non-invasive tissue ablation dates back to investigations reported by Lynn et al. in 1942. However, its therapeutic application in humans gained momentum in the mid-20th century, primarily through the pioneering work of American experimental physicists William and Francis Fry and their colleagues in the 1950s and 1960s.
HIFU’s Landmark Introduction for Prostate Health in Nigeria
In Nigeria, HIFU made its debut for prostate cancer treatment in December 2025, marking a significant milestone. The first centre to deploy the Sinabkate HIFU system for prostate cancer and enlargement care was TPC, thereby establishing itself as a pioneer not only in Nigeria but also across West Africa.
Professor Kingsley Ekwueme, a Nigerian-United Kingdom-trained robotic and laparoscopic surgeon, spearheaded the introduction of this technology into the Nigerian medical system. He described HIFU as “small but mighty,” emphasizing its transformative potential for prostate health in Nigeria and the broader West and Central African regions. Professor Ekwueme’s motivation stemmed from a strong desire to combat substandard cancer care in Nigeria and to mirror the high standards of medical services he provided in the UK, ensuring Nigerians have access to world-class treatment options.
“Right here, I want men in Nigeria to have first-class treatment like my patients in the UK. We are training Nigerian medical practitioners on the new system, and this underscores TPC’s commitment to building local capacity and reducing medical tourism,” he stated.
How HIFU Works for Prostate Conditions
The HIFU system delivers high-intensity ultrasound energy directly to cancerous tissue within the prostate, precisely destroying it while leaving adjacent healthy tissue unharmed. This is achieved through a fully automated, artificial intelligence-driven machine. Clinicians input imaging data that precisely maps the cancer’s location. With a single click, the system initiates targeted treatment, with clinicians monitoring visual cues on a screen that confirm the complete eradication of cancer. Upon completion, the machine automatically shuts down.
A key advantage of HIFU in prostate cancer treatment is its nature as a focal therapy. This means only the cancerous portion of the prostate is targeted, rather than requiring the removal of the entire gland. This is particularly vital in Nigeria, where hereditary prostate cancer often affects younger men, up to seven years earlier than in other populations, who may still wish to father children.
Professor Ekwueme highlighted the profound implications of this focal approach: “With this technology, you can fully cure the cancer in the prostate while the prostate remains intact. Erection is preserved, ejaculation is preserved, there is no urine leakage and no pain. That means you can still father a child naturally.”
The side effects commonly associated with traditional prostate cancer treatments, such as urinary incontinence, erectile dysfunction, and loss of ejaculation, are virtually eliminated with HIFU. Most patients require only mild pain relief, such as paracetamol, post-procedure.
Professor Ekwueme’s commitment to bringing this technology home underscores his vision: “I returned home because I wanted to make a difference. Our country deserves the best treatments available anywhere in the world. I don’t want any Nigerian man to receive substandard care.” He expressed immense satisfaction in seeing Nigerian medical professionals trained and equipped to deliver this advanced care, signaling a reduction in the need for medical tourism for advanced cancer treatment.
HIFU: A Beacon of Hope for Uterine Fibroids and Adenomyosis
The application of HIFU extends beyond prostate health. In 2021, Dr. Abayomi Ajayi, a Consultant Obstetrician and Gynaecologist, introduced HIFU for the treatment of uterine fibroids and adenomyosis in Nigeria. This non-invasive option was warmly welcomed by women seeking alternatives to invasive surgery.
Dr. Ajayi, Managing Director of Nordica Fertility Centre, Ikoyi, Lagos, explained that during the HIFU procedure, ultrasound energy is converted into heat, which effectively destroys fibroids and their blood supply. The procedure typically takes one to two hours, depending on the size and number of fibroids. For patients with multiple fibroids, the treatment may be performed in stages over several sessions.
Since its introduction in 2021, the Nordica Fibroid Care Centre in Lagos, a pioneer of HIFU for fibroids in Nigeria, has successfully treated over 730 women, with the number continuing to grow. Long-term follow-ups have demonstrated a significant reduction in fibroid symptoms and a return to normal life for treated patients. HIFU is increasingly recognized as a revolutionary, fertility-preserving approach.
For women in Nigeria, where fibroids are particularly prevalent and often undertreated, HIFU offers a vital alternative, providing hope and a life-changing solution. It allows women to undergo safe, non-invasive treatment, recover quickly, and preserve their fertility, a stark contrast to the potential risks associated with surgical interventions that might compromise their ability to conceive.
Dr. Amarachukwu Njoku, a specialist in HIFU and an obstetrician/gynaecologist, outlined the ideal candidates for this treatment. Women diagnosed with uterine fibroids or adenomyosis are eligible. Furthermore, women who have previously undergone fibroid surgery and continue to experience symptoms, as well as those with adenomyosis (a condition involving bleeding within the uterine muscle), can also benefit from HIFU.
The “Game-Changer” Advantage: Precision and Minimal Side Effects
The United States of America Urology Specialists highlight precision as a paramount advantage of HIFU, particularly when guided by magnetic resonance imaging (MRI). This precision allows for targeted ablation, enabling clinicians to destroy cancer cells while meticulously sparing surrounding healthy tissue, thereby aiming for outcomes where surrounding tissue remains unharmed.
This targeted approach significantly reduces the risk of major side effects, such as severe incontinence or long-term erectile dysfunction, when compared to radical surgery or radiation therapy.
“For the right candidate, HIFU can be a very effective cancer-control method. HIFU treatment for prostate cancer offers the potential for effective cancer control, fewer side effects, specifically a reduced risk of urinary incontinence and erectile dysfunction, and faster recovery compared to traditional radical treatments like surgery or radiation therapy,” stated the US Urology Specialists on their official portal. This underscores HIFU’s growing role as a superior alternative in modern medical management.
